Dr. Igor Lev
Angestellt, Senior manager fermentation, Formo Bio GmbH
Frankfurt am Main, Deutschland
Werdegang
Berufserfahrung von Igor Lev
Bis heute 2 Jahre und 2 Monate, seit Mai 2022
Senior manager fermentation
Formo Bio GmbH
My current role is to lead all fermentation activities in the company with a team of 5. Formo is a food biotech company on a mission to bring the next generation of sustainable, healthy, and equitable dairy products to consumers.
2 Jahre und 7 Monate, Juni 2020 - Dez. 2022
Head of Bioprocess
Mybiotics
The focus of my work as department head was to lead the development of upstream and downstream processes for all of the company's products. I managed a group of upstream and downstream scientists. I collaborated with the data science, computational biology, IP, and business development teams to ensure the alignment of research activities with company goals.
11 Monate, Aug. 2019 - Juni 2020
Bioprocess engineer
Mybiotics
Achieved ten times increase in biomass production by optimizing cultivation conditions and medium composition. • Developed the anaerobic cultivation conditions for more than 30 strains. • Planned and designed a wide variety of experiments for overall small improvements and perform further statistical analysis of data. • Strengthened and applied knowledge of GMP and GLP to process development and scale-up.
2018 - 2019
Research Scientist
Biocad
• Achieved an increase in mAb yield by 50%, modifying the feed supply scheme • Developed the conditions for the cultivation of HEK-cells, which led to an increase in survival by 2 times • Developed and implemented a pH control system for fed-batch and perfusion cultivation based on accurate glucose supply, which reduced process costs and increased repeatability. • Successfully scaled 2 CHO cell lines to 3000 liters with a loss of productivity of less than 2%.
6 Jahre, Sep. 2012 - Aug. 2018
Research Scientist
State research centre for applied microbiology and biotechnology
• Successfully created a prototype of the antimycotic drug for veterinary use, which passed preliminary animal clinical trials. • Managed a project to develop high-density cultivation of yeast technology for more than 150 strains. • Successfully identified, described, and typed a strain exhibiting antagonistic activity against pathogenic fungi, which later became the producer of the active component.
Ausbildung von Igor Lev
6 Jahre, Sep. 2012 - Aug. 2018
Biotechnology
State Research Center for Applied Microbiology
4 Jahre und 9 Monate, Sep. 2007 - Mai 2012
Genetics
Chelyabinsk State University
Sprachen
Englisch
Fließend
Deutsch
Grundlagen
Hebräisch
Gut
Russisch
Fließend